Clinical Trials on Muscular Dystrophies in New Zealand
Total 5180 results
-
Arrowhead PharmaceuticalsRecruitingFacio-Scapulo-Humeral DystrophyNew Zealand
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Dyne TherapeuticsRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, France, Netherlands, Italy, Germany, New Zealand
-
AMO Pharma LimitedRecruitingCongenital Myotonic DystrophyUnited States, Canada, Australia, New Zealand
-
Shockwave Medical, Inc.Completed
-
AMO Pharma LimitedCompletedCongenital Myotonic DystrophyUnited States, Canada, New Zealand, Australia, United Kingdom
-
EndologixCompletedPeripheral Arterial DiseaseNew Zealand
-
Avinger, Inc.WithdrawnPeripheral Arterial DiseaseNew Zealand
-
Pfenex, IncCompletedAge Related Macular Degeneration (AMD)New Zealand
-
Terumo Medical CorporationRecruiting
-
Waikato HospitalEnrolling by invitation
-
W.L.Gore & AssociatesCompletedPeripheral Arterial Disease | Common Iliac Artery Occlusive Disease | External Iliac Artery Occlusive DiseaseNew Zealand
-
Intervene, Inc.Terminated
-
Virginia Commonwealth UniversityRadboud University Medical Center; University of California, Los Angeles; University... and other collaboratorsRecruitingMyotonic Dystrophy 1United States, Netherlands, United Kingdom, New Zealand, Germany, Italy, Canada, France
-
Spectranetics CorporationCompletedPeripheral Artery DiseaseNew Zealand
-
TriReme Medical, LLCCompletedPeripheral Vascular DiseaseNew Zealand, Germany
-
University of Auckland, New ZealandCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBecker Muscular Dystrophy | Facioscapulohumeral Muscular Dystrophy | Limb-Girdle Muscular DystrophyUnited States
-
University of Auckland, New ZealandCompletedPostoperative Pain | HemorrhoidsNew Zealand
-
Medtronic VascularCompletedMyocardial Ischemia | Coronary Artery DiseaseNew Zealand
-
University of Auckland, New ZealandHealth Research Council, New ZealandCompleted
-
University of RochesterCompletedFacioscapulohumeral Muscular DystrophyUnited States
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.Active, not recruitingDuchenne Muscular DystrophyKorea, Republic of, Chile, Japan, China, United Kingdom, Netherlands, Spain, Norway, Russian Federation, Australia, Greece, Italy, New Zealand, Turkey, Mexico, Czechia, Canada
-
Zealand University HospitalUniversity of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...CompletedDepression | Acute Coronary SyndromeDenmark
-
Newcastle-upon-Tyne Hospitals NHS TrustJain FoundationActive, not recruitingDysferlinopathy | LGMD2B Now Classified as LGMDR2 | Miyoshi MyopathyKorea, Republic of, Chile, Spain, United States, Denmark, France, Italy, Japan, United Kingdom
-
NeuroActiva, Inc.CompletedNeurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive DisorderNew Zealand
-
Lumen BiomedicalCompletedFresh Soft Emboli or Thrombi in the Arteries.New Zealand
-
Route 92 Medical, Inc.CompletedAcute Ischemic StrokeNew Zealand
-
Benitec Biopharma, Inc.RecruitingOculopharyngeal Muscular DystrophyUnited States
-
Atrium Medical CorporationTerminatedCoronary Artery DiseaseNew Zealand
-
Phoenix Tissue Repair, Inc.Phoenix Tissue Repair, a BridgeBio companyCompletedRecessive Dystrophic Epidermolysis BullosaUnited States
-
EndologixCompletedJuxtarenal Aortic Aneurysm | Pararenal Aortic AneurysmNew Zealand, Chile
-
Columbia UniversityTerminatedEpidermolysis BullosaUnited States
-
Efemoral Medical, Inc.RecruitingVascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal StenosisNew Zealand, Australia
-
Sarepta Therapeutics, Inc.Active, not recruitingMuscular Dystrophy, DuchenneUnited States, Korea, Republic of, India, Slovenia, Turkey, United Kingdom, Germany, Switzerland, Spain, Czechia, France, Serbia, Taiwan, Netherlands, Mexico, Colombia, Denmark, New Zealand, Norway, Greece, Hungary, Ireland, Italy, Jo... and more
-
Shape Memory Medical, Inc.Active, not recruitingAbdominal Aortic AneurysmNew Zealand
-
OcuNexus Therapeutics, Inc.TerminatedDiabetic Foot UlcerNew Zealand
-
NS Pharma, Inc.Nippon Shinyaku Co., Ltd.CompletedDuchenne Muscular DystrophyKorea, Republic of, Chile, Taiwan, China, United States, United Kingdom, Netherlands, Spain, Australia, Norway, Russian Federation, Greece, Italy, Turkey, Mexico, Canada, Hong Kong, New Zealand, Ukraine
-
Karyopharm Therapeutics IncWithdrawnDiabetic Foot UlcersNew Zealand
-
PepGen IncRecruitingDuchenne Muscular DystrophyCanada
-
Shockwave Medical, Inc.Active, not recruitingPeripheral Arterial DiseaseNew Zealand, Australia
-
Medtronic VascularCompletedUncontrolled HypertensionAustralia, New Zealand
-
University of ReadingMassey UniversityCompletedHypertensionNew Zealand
-
Ultragenyx Pharmaceutical IncCompletedHereditary Inclusion Body Myopathy (HIBM)United States
-
Kona Medical Inc.CompletedHypertensionCzech Republic, New Zealand
-
Avidity Biosciences, Inc.RecruitingPhase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, United Kingdom, Canada
-
Elixir Medical CorporationCompletedCoronary Artery DiseaseNew Zealand, Belgium
-
Syneos HealthDr. Reddy's Laboratories LimitedCompletedRheumatoid Arthritis | Giant Cell ArteritisNew Zealand, Australia, India
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, Netherlands, France, Italy
-
Santhera PharmaceuticalsNo longer availableDuchenne Muscular DystrophyUnited States